South Korea
· Delayed Price · Currency is KRW From Bio Co.,Ltd Statistics
Total Valuation
From Bio Co.,Ltd has a market cap or net worth of KRW 62.00 billion. The enterprise value is 76.17 billion.
| Market Cap | 62.00B |
| Enterprise Value | 76.17B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
From Bio Co.,Ltd has 28.31 million shares outstanding.
| Shares Outstanding | 28.31M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 39.24% |
| Owned by Institutions (%) | 9.03% |
| Float | 17.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.92 |
| PB Ratio | 0.93 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.58 |
| EV / Sales | 1.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.80 |
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.64 |
| Quick Ratio | 0.48 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.87 |
| Interest Coverage | -35.04 |
Financial Efficiency
Return on equity (ROE) is -22.90% and return on invested capital (ROIC) is -15.45%.
| Return on Equity (ROE) | -22.90% |
| Return on Assets (ROA) | -14.39% |
| Return on Capital (ROIC) | -15.45% |
| Revenue Per Employee | 525.69M |
| Profits Per Employee | -130.04M |
| Employee Count | 128 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 0.96 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.56% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -67.56% |
| 50-Day Moving Average | 2,050.68 |
| 200-Day Moving Average | 3,121.67 |
| Relative Strength Index (RSI) | 50.74 |
| Average Volume (20 Days) | 176,668 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, From Bio Co.,Ltd had revenue of KRW 67.29 billion and -16.64 billion in losses. Loss per share was -587.95.
| Revenue | 67.29B |
| Gross Profit | 45.38B |
| Operating Income | -22.10B |
| Pretax Income | -22.43B |
| Net Income | -16.64B |
| EBITDA | -19.99B |
| EBIT | -22.10B |
| Loss Per Share | -587.95 |
Balance Sheet
The company has 8.70 billion in cash and 23.56 billion in debt, giving a net cash position of -14.85 billion or -524.62 per share.
| Cash & Cash Equivalents | 8.70B |
| Total Debt | 23.56B |
| Net Cash | -14.85B |
| Net Cash Per Share | -524.62 |
| Equity (Book Value) | 65.71B |
| Book Value Per Share | 2,345.18 |
| Working Capital | 14.58B |
Cash Flow
In the last 12 months, operating cash flow was -24.52 billion and capital expenditures -2.64 billion, giving a free cash flow of -27.16 billion.
| Operating Cash Flow | -24.52B |
| Capital Expenditures | -2.64B |
| Free Cash Flow | -27.16B |
| FCF Per Share | -959.37 |
Margins
Gross margin is 67.44%, with operating and profit margins of -32.85% and -24.74%.
| Gross Margin | 67.44% |
| Operating Margin | -32.85% |
| Pretax Margin | -33.33% |
| Profit Margin | -24.74% |
| EBITDA Margin | -29.71% |
| EBIT Margin | -32.85% |
| FCF Margin | -40.36% |
Dividends & Yields
From Bio Co.,Ltd does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -26.85% |
| FCF Yield | -43.81% |
Stock Splits
The last stock split was on March 13, 2024. It was a forward split with a ratio of 2.
| Last Split Date | Mar 13, 2024 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
From Bio Co.,Ltd has an Altman Z-Score of 2.16. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.16 |
| Piotroski F-Score | n/a |